Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy

Bibliographic Details
Main Authors:	Ismail Tevfik F, Jabbour Andrew, Gulati Ankur, Mallorie Amy, Raza Sadaf, Cowling Thomas E, Das Bibek, Khwaja Jahanzaib, Wage Rick, Moon James, Varnava Amanda, Shakespeare Carl, Elliott Perry, OHanlon Rory, Pennell Dudley J, Prasad Sanjay K
Format:	Article
Language:	English
Published:	Elsevier 2013-01-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
by: Ismail Tevfik F, et al.
Published: (2012-02-01)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)

2056 Quantitative magnetic resonance first-pass perfusion analysis in hypertrophic cardiomyopathy. Intrastudy variability
by: Pennell Dudley J, et al.
Published: (2008-10-01)

The relationship between interstitial fibrosis and contractile function in HCM: a combined T1-mapping and CSPAMM tagging study
by: Ismail Tevfik F, et al.
Published: (2012-02-01)

Bolus administration T1 mapping as a marker of interstitial myocardial fibrosis in severe aortic stenosis
by: Wage Rick, et al.
Published: (2012-02-01)

Sudden death in hypertrophic cardiomyopathy.
by: Watkins, H
Published: (2000)

The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death
by: Pedro Freitas, et al.
Published: (2019-08-01)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
by: Prasad Sanjay, et al.
Published: (2009-01-01)

Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy
by: Gaston A. Rodriguez-Granillo, et al.
Published: (2016-01-01)

Prevention of Sudden Death in Hypertrophic Cardiomyopathy
by: Edmundo Arteaga-Fernández, et al.

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
by: Christina Doesch, et al.
Published: (2017-07-01)

Sudden cardiac death in hypertrophic cardiomyopathy: Improved risk stratification strategies are needed
by: Inês Cruz
Published: (2019-12-01)

Further refining risk in hypertrophic cardiomyopathy with late gadolinium enhancement by CMR
by: Kramer, C, et al.
Published: (2018)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
by: Smith Brandon M, et al.
Published: (2013-01-01)

The Association between the Extent of Late Gadolinium Enhancement and Diastolic Dysfunction in Hypertrophic Cardiomyopathy
by: Deniz Alis, et al.
Published: (2021-04-01)

Acquiring multiple slices in a single breath-hold. Is it practical for routine workflow?
by: Pennell Dudley J, et al.
Published: (2009-01-01)

Rapid assessment of myocardial scar and viability in ischemic heart disease: a cardiovascular magnetic resonance study
by: Wage Rick, et al.
Published: (2009-01-01)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
by: Jassal Davinder S, et al.
Published: (2008-12-01)

Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy
by: Ana Raquel Barbosa, et al.
Published: (2020-11-01)

SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY: SEARCH FOR NEW RISK FACTORS
by: N. S. Krylova, et al.
Published: (2017-02-01)

2015 Myocardial perfusion after percutaneous recanalization of coronary chronic total occlusions: a cardiovascular magnetic resonance study
by: Prasad Sanjay K, et al.
Published: (2008-10-01)

Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy
by: Zhang, Q, et al.
Published: (2021)

Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
by: Yan Dong, et al.
Published: (2021-08-01)

Utility of late gadolinium enhancement on magnetic resonance imaging in hypertrophic cardiomyopathy patients in an Indian cohort
by: Harikrishnan Gangadharakaimal, et al.
Published: (2023-09-01)

Cardiovascular magnetic resonance T2 mapping detects myocardial edema in patients with chronic dilated cardiomyopathy
by: He Taigang, et al.
Published: (2012-02-01)

Effects of anabolic steroid use on myocardial perfusion in body-builders: a quantitative cardiovascular magnetic resonance Study
by: Ismail Tevfik F, et al.
Published: (2013-01-01)

Sudden Cardiac Death in Hypertrophic Cardiomyopathy: Hig-risk Factors and Prevention
by: PAN Yuhui, et al.
Published: (2023-05-01)

Prognostic significance of ventricular function and late gadolinium enhancement on CMR in symptomatic patients with scleroderma
by: Natarajan Arun, et al.
Published: (2013-01-01)

The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease
by: Shengliang Liu, et al.
Published: (2022-05-01)

High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy.
by: Tetsuo Konno, et al.
Published: (2014-01-01)

Non-invasive assessment of interstitial myocardial fibrosis in pressure-overload left ventricular hypertrophy
by: Jabbour Andrew, et al.
Published: (2012-02-01)

Hypertrophic cardiomyopathy and ultra-endurance running - two incompatible entities?
by: Wilson Mathew G, et al.
Published: (2011-11-01)

Quantitative assessment of myocardial extracellular volume fraction in non-ischemic dilated cardiomyopathy and its relation to systolic dysfunction
by: Ali Aamir, et al.
Published: (2013-01-01)

Asymmetric Hypertrophic Cardiomyopathy in Athletes: Always a Higher Risk for Sudden Death?
by: Rafael Thiesen Magliari, et al.
Published: (2020-11-01)

Asymmetric Hypertrophic Cardiomyopathy in Athletes: Always a Higher Risk for Sudden Death?
by: Rafael Thiesen Magliari, et al.
Published: (2020-11-01)

Asymmetric Hypertrophic Cardiomyopathy in Athletes: Always a Higher Risk for Sudden Death?
by: Rafael Thiesen Magliari, et al.
Published: (2020-11-01)

Risk of sudden cardiac death in childhood hypertrophic cardiomyopathy: Time to solve the mystery
by: Gabrielle Norrish, et al.
Published: (2018-01-01)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
by: Hua Shen, et al.
Published: (2022-08-01)

HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH POLYARTERITIS NODOSA: A CASE OF SUDDEN CARDIAC DEATH
by: Elvira Ventura Spagnolo
Published: (2018-12-01)

Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?
by: Liliana Reis, et al.